News
09-27-2010, 04:40 AM
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced that it has received Australian Therapeutic Goods Administration approval for its biosimilar filgrastim product, Nivestim.
More... (http://www.news-medical.net/news/20100927/Hospiras-Nivestim-receives-Australian-TGA-approval.aspx)
More... (http://www.news-medical.net/news/20100927/Hospiras-Nivestim-receives-Australian-TGA-approval.aspx)